Ironwood Pharmaceuticals | Des Atouts



Assets Changement Date
Acadia Pharmaceuticals USD 1.23B 93.19M 2025-06
Agios Pharmaceuticals USD 1.47B 84.28M 2025-06
Almirall EUR 2.31B 88.18M 2025-06
Alnylam Pharmaceuticals USD 4.57B 352.21M 2025-06
Amarin USD 655.68M 29.67M 2025-03
Ardelyx USD 435.75M 67.89M 2024-12
Astellas Pharma JPY 3.34T 3.71B 2025-06
AstraZeneca USD 112.42B 6.17B 2025-06
Charles River Laboratories USD 7.56B 21.82M 2025-06
Exact Sciences USD 5.8B 86.29M 2025-06
Halozyme Therapeutics USD 2.05B 142.63M 2025-06
Incyte USD 5.82B 71.99M 2025-06
Ironwood Pharmaceuticals USD 351.3M 38.22M 2024-12
MacroGenics USD 261.65M 2.84M 2024-12
Moderna USD 12.01B 694M 2025-06
Myriad Genetics USD 1.01B 21.5M 2025-03
Pacira USD 1.54B 49.41M 2025-06
PTC Therapeutics USD 2.63B 21.23M 2025-06
Sarepta Therapeutics USD 3.68B 214.43M 2025-06
Takeda JPY 14T 243.81B 2025-06
Ultragenyx Pharmaceutical USD 1.31B 5.66M 2025-06


Ironwood Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.